Aptiv (NYSE: APTV) Q1 2026 Results: Revenue Rises, Versigent Spin-Off Completes

Aptiv PLC (NYSE: APTV) reported a rise in first-quarter 2026 revenue and net income on Tuesday, supported by sustained demand for auto parts — including advanced driver-assistance systems — while the stock slipped $0.96 (1.59%) to $59.53 against a prior close of $60.49. The quarter also marked a structural milestone: the spin-off of the company's Electrical Distribution Systems business into a new publicly traded entity, Versigent, completed on April 1, 2026.

Q1 2026 At a Glance

• Revenue growth (YoY): 5.0%, driven by continued auto parts demand
• Gross margin: 19.1%
• Operating margin: 10.3%
• Net margin: 0.8%, reflecting the weight of below-the-line items
• Trailing P/E: 79.4x | Forward P/E: 8.9x — a wide gap signalling expected earnings normalization
• Earnings growth (YoY): -43.4% on a net income basis
• SEC 8-K filed: May 5, 2026 (Results of Operations, Item 2.02)

What Drove the Results

Top-line momentum was anchored by demand for advanced driver-assistance systems and broader auto components, areas where Aptiv has maintained a meaningful technology position. The 5.0% year-over-year revenue gain demonstrates that end-market demand remains constructive even as broader automotive production volumes face cyclical headwinds.

The sharp decline in year-over-year net income — down 43.4% — alongside an unusually thin net margin of 0.8% suggests that below-operating-line costs, restructuring, or one-time items weighed materially on the bottom line this quarter. The Q1 2026 results also incorporate the Versigent spin-off, completed April 1, 2026, which removes the Electrical Distribution Systems segment from Aptiv's consolidated financials going forward, making direct quarter-over-quarter comparisons more complex.

Wall Street View

Analyst sentiment on Aptiv (NYSE: APTV) remains firmly constructive. As of the May 1, 2026 consensus, 9 analysts rate the stock Strong Buy, 18 rate it Buy, and 4 Hold, with zero Sell or Strong Sell ratings. Compared to the April 1, 2026 snapshot — 9 Strong Buy, 17 Buy, 4 Hold — one additional Buy was added, suggesting the analyst community is modestly more positive heading into the post-spin restructuring phase.

Investor Takeaway

The wide divergence between Aptiv's trailing P/E of 79.4x and forward P/E of 8.9x implies that the market is pricing in a significant recovery in net income once spin-off-related costs and one-time items normalize. With 31 of 31 covering analysts holding Buy-equivalent ratings and no Sell recommendations on record, Wall Street appears to view the current $59.53 price — near the lower end of the 52-week range of $56.56–$88.93 — as an opportunity tied to the company's repositioned, post-Versigent business profile.